- Home
- ALGS vs IOBT Comparison
ALGS vs IOBT Comparison
Compare ALGS & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- IOBT
- Stock Information
- Founded
- ALGS 2018
- IOBT 2014
- Country
- ALGS United States
- IOBT Denmark
- Employees
- ALGS N/A
- IOBT 78
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- ALGS Health Care
- IOBT Health Care
- Exchange
- ALGS Nasdaq
- IOBT Nasdaq
- Market Cap
- ALGS 56.7M
- IOBT 57.2M
- IPO Year
- ALGS 2020
- IOBT 2021
- Fundamental
- Price
- ALGS $9.74
- IOBT $0.71
- Analyst Decision
- ALGS Strong Buy
- IOBT Buy
- Analyst Count
- ALGS 2
- IOBT 4
- Target Price
- ALGS $60.00
- IOBT $3.50
- AVG Volume (30 Days)
- ALGS 90.2K
- IOBT 993.9K
- Earning Date
- ALGS 11-06-2025
- IOBT 11-14-2025
- Dividend Yield
- ALGS N/A
- IOBT N/A
- EPS Growth
- ALGS N/A
- IOBT N/A
- EPS
- ALGS N/A
- IOBT N/A
- Revenue
- ALGS $2,646,000.00
- IOBT N/A
- Revenue This Year
- ALGS N/A
- IOBT N/A
- Revenue Next Year
- ALGS N/A
- IOBT N/A
- P/E Ratio
- ALGS N/A
- IOBT N/A
- Revenue Growth
- ALGS N/A
- IOBT N/A
- 52 Week Low
- ALGS $3.76
- IOBT $0.32
- 52 Week High
- ALGS $46.80
- IOBT $2.79
- Technical
- Relative Strength Index (RSI)
- ALGS 62.50
- IOBT 42.35
- Support Level
- ALGS $5.81
- IOBT $0.70
- Resistance Level
- ALGS $7.00
- IOBT $0.83
- Average True Range (ATR)
- ALGS 0.79
- IOBT 0.11
- MACD
- ALGS 0.38
- IOBT -0.00
- Stochastic Oscillator
- ALGS 88.61
- IOBT 21.26
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.